IGC Pharma (IGC) Accounts Payables (2011 - 2026)
IGC Pharma's Accounts Payables came in at $1.26 million for Q4 2026, up 42.1% from $883,000 a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Accounts Payables (2011 - 2026) Analysis & Trends
Going back to Q4 2011, IGC Pharma's Accounts Payables data covers 61 quarters.
- Accounts Payables has increased in each of the last three years, though with a five-year compound annual growth rate of -4.6% (FY2021 to FY2026).
- Going back by year, Accounts Payables was $883,000 in FY2025 (+14.2%), $773,000 in FY2024 (+45.8%), $530,000 in FY2023 (-63.7%) and $1.46 million in FY2022 (-8.1%).
- The Q4 2026 figure represents the highest quarterly Accounts Payables since Q2 2024.
- Year-over-year, Accounts Payables increased in five of the last eight quarters, with growth averaging 1.5%.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2024 (growth of 68.1%), and the weakest in Q4 2023 (a decline of 63.7%).
- Business Quant data shows IGC's Accounts Payables at $1.01 million (Q3 2026), $628,000 (Q2 2026) and $933,000 (Q1 2026) in the three quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 | 1.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 933,000.00 |
| Mar 31, 2025 | 883,000.00 |
| Dec 31, 2024 | 835,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 771,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 530,000.00 |
| Dec 31, 2022 | 890,000.00 |
| Sep 30, 2022 | 926,000.00 |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 919,000.00 |
| Sep 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.54 Mn |
API Access
IGC Pharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();